{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:09:48Z","timestamp":1767827388507,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T00:00:00Z","timestamp":1464566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11154-016-9362-3","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T01:32:05Z","timestamp":1464571925000},"page":"419-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Endocrine manifestations of systemic mastocytosis in bone"],"prefix":"10.1007","volume":"17","author":[{"given":"Loren Wissner","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Asadipooya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Freitas","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"issue":"2","key":"9362_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin N Am. 2014;34(2):283\u201395.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"9","key":"9362_CR2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","volume":"80","author":"P Valent","year":"1992","unstructured":"Valent P, Spanbl\u00f6chl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture. Blood. 1992;80(9):2237\u201345.","journal-title":"Blood"},{"issue":"23","key":"9362_CR3","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, et al. Systemic mastocytosis in 342 consecutive adults: Survival studies and prognostic factors. Blood. 2009;113(23):5727\u201336.","journal-title":"Blood"},{"key":"9362_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","volume":"55","author":"C Akin","year":"2004","unstructured":"Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med. 2004;55:419\u201332.","journal-title":"Annu Rev Med"},{"issue":"19","key":"9362_CR5","first-page":"1885","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015;373(19):1885\u20136.","journal-title":"N Engl J Med"},{"issue":"11","key":"9362_CR6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","volume":"12","author":"SJ Galli","year":"2011","unstructured":"Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nat Immunol. 2011;12(11):1035\u201344.","journal-title":"Nat Immunol"},{"issue":"2","key":"9362_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1309\/Q2WJ-46CL-YRFT-M5JF","volume":"116","author":"EC Stevens","year":"2001","unstructured":"Stevens EC, Rosenthal NS. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease. Am J Clin Pathol. 2001;116(2):177\u201382.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"9362_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.22125","volume":"53","author":"A Uzzaman","year":"2009","unstructured":"Uzzaman A, Maric I, Noel P, Kettelhut BV, Metcalfe DD, Carter MC. Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer. 2009;53(4):629\u201334.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"9362_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/modpathol.2013.117","volume":"27","author":"S Berezowska","year":"2014","unstructured":"Berezowska S, Flaig MJ, Ru\u00ebff F, Walz C, Haferlach T, Krokowski M, et al. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol. 2014;27(1):19\u201329.","journal-title":"Mod Pathol"},{"issue":"8","key":"9362_CR10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jbmr.5650050811","volume":"5","author":"C Lidor","year":"1990","unstructured":"Lidor C, Frisch B, Gazit D, Gepstein R, Hallel T, Mekori YA. Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Miner Res. 1990;5(8):871\u20136.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"9362_CR11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-015-9969-5","volume":"96","author":"M Rossini","year":"2015","unstructured":"Rossini M, Viapiana O, Zanotti R, Tripi G, Perbellini O, Idolazzi L, et al. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis. Calcif Tissue Int. 2015;96(5):410\u20136.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"9362_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4274\/tjh.2013.0170","volume":"32","author":"N Alpay Kan\u0131tez","year":"2015","unstructured":"Alpay Kan\u0131tez N, Erer B, Do\u011fan \u00d6, B\u00fcy\u00fckbabani N, Baykal C, Sindel D, et al. Osteoporosis and osteopathy markers in patients with mastocytosis. Turk J Haematol. 2015;32(1):43\u201350.","journal-title":"Turk J Haematol"},{"issue":"6","key":"9362_CR13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2014.05.003","volume":"134","author":"E Veer Van der","year":"2014","unstructured":"Van der Veer E, Arends S, van der Hoek S, Versluijs JB, de Monchy JG, Oude Elberink JN, et al. Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis. J Allergy Clin Immunol. 2014;134(6):1413\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"9362_CR14","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00198-013-2305-x","volume":"24","author":"S Seitz","year":"2013","unstructured":"Seitz S, Barvencik F, Koehne T, Priemel M, Pogoda P, Semler J, et al. Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos Int. 2013;24(8):2325\u201334.","journal-title":"Osteoporos Int"},{"issue":"1","key":"9362_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjmed.2012.07.018","volume":"126","author":"N Guillaume","year":"2013","unstructured":"Guillaume N, Desoutter J, Chandesris O, Merlusca L, Henry I, Georgin-Lavialle S, et al. Bone complications of mastocytosis: A link between clinical and biological characteristics. Am J Med. 2013;126(1):75. e1-7.","journal-title":"Am J Med"},{"issue":"3","key":"9362_CR16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","volume":"67","author":"E Veer Van der","year":"2012","unstructured":"Van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy. 2012;67(3):431\u20138.","journal-title":"Allergy"},{"issue":"8","key":"9362_CR17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjmed.2011.02.038","volume":"124","author":"M Laroche","year":"2011","unstructured":"Laroche M, Livideanu C, Paul C, Cantagrel A. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis. Am J Med. 2011;124(8):776\u20138.","journal-title":"Am J Med"},{"issue":"4","key":"9362_CR18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini M, Zanotti R, Bonadonna P, Artuso A, Caruso B, Schena D, et al. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone. 2011;49(4):880\u20135.","journal-title":"Bone"},{"issue":"10","key":"9362_CR19","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","volume":"69","author":"S Barete","year":"2010","unstructured":"Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, et al. Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis. 2010;69(10):1838\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"9362_CR20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","volume":"124","author":"L Escribano","year":"2009","unstructured":"Escribano L, Alvarez-Twose I, S\u00e1nchez-Mu\u00f1oz L, Garcia-Montero A, N\u00fa\u00f1ez R, Almeida J, et al. Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol. 2009;124(3):514\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"9362_CR21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjmed.2014.06.015","volume":"127","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Idolazzi L, Biondan M, et al. Zoledronic acid in osteoporosis secondary to mastocytosis. Am J Med. 2014;127(11):1127. e1-4.","journal-title":"Am J Med"},{"issue":"5","key":"9362_CR22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2013.06.019","volume":"132","author":"A Rabenhorst","year":"2013","unstructured":"Rabenhorst A, Christopeit B, Leja S, Gerbaulet A, Kleiner S, F\u00f6rster A, et al. Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis. J Allergy Clin Immunol. 2013;132(5):1234\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9362_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000091172","volume":"139","author":"NM Kushnir-Sukhov","year":"2006","unstructured":"Kushnir-Sukhov NM, Brittain E, Reynolds JC, Akin C, Metcalfe DD. Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis. Int Arch Allergy Immunol. 2006;139(3):265\u201370.","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"9362_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ageing\/25.1.1","volume":"25","author":"C Johansson","year":"1996","unstructured":"Johansson C, Roupe G, Lindstedt G, Mellstr\u00f6m D. Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing. 1996;25(1):1\u20137.","journal-title":"Age Ageing"},{"issue":"6","key":"9362_CR25","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.4158\/EP12062.CR","volume":"18","author":"JD Abramowitz","year":"2012","unstructured":"Abramowitz JD. Weinerman SA Osteoporosis as the sole manifestation of systemic mastocytosis in a young man. Endocr Pract. 2012;18(6):e158\u2013161.","journal-title":"Endocr Pract"},{"issue":"2","key":"9362_CR26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, et al. Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin N Am. 2014;34(2):383\u201396.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"1","key":"9362_CR27","first-page":"66","volume":"6","author":"M Benucci","year":"2009","unstructured":"Benucci M, Bettazzi C, Bracci S, Fabiani P, Monsacchi L, Cappelletti C, et al. Systemic mastocytosis with skeletal involvement: A case report and review of the literature. Clin Cases Miner Bone Metab. 2009;6(1):66\u201370.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"5","key":"9362_CR28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/jbmr.2456","volume":"30","author":"M Rossini","year":"2015","unstructured":"Rossini M, Viapiana O, Adami S, Idolazzi L, Zanotti R, Gatti D. Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected]. J Bone Miner Res. 2015;30(5):945.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"9362_CR29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0960-9822(01)00290-1","volume":"11","author":"MV Sem\u00ebnov","year":"2001","unstructured":"Sem\u00ebnov MV, Tamai K, Brott BK, K\u00fchl M, Sokol S, He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol. 2001;11(12):951\u201361.","journal-title":"Curr Biol"},{"issue":"10","key":"9362_CR30","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1073\/pnas.0934373100","volume":"100","author":"LA Fitzpatrick","year":"2003","unstructured":"Fitzpatrick LA, Buzas E, Gagne TJ, Nagy A, Horvath C, Ferencz V, et al. Targeted deletion of histidine decarbosylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci USA. 2003;100(10):6027\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"9362_CR31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jbmr.5650051104","volume":"5","author":"L Graves 3rd","year":"1990","unstructured":"Graves 3rd L, Stechschulte DJ, Morris DC, Lukert BP. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Miner Res. 1990;5(11):1113\u20139.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"9362_CR32","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1359\/jbmr.070605","volume":"22","author":"RR Pochampally","year":"2007","unstructured":"Pochampally RR, Ylostalo J, Penfornis P, Matz RR, Smith JR, Prockop DJ. Histamine receptor H1 and dermatopontin: New downstream targets of the vitamin D receptor. J Bone Miner Res. 2007;22(9):1338\u201349.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"9362_CR33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2006.03.004","volume":"36","author":"N Chiappetta","year":"2006","unstructured":"Chiappetta N, Gruber B. The role of mast cells in osteoporosis. Semin Arthritis Rheum. 2006;36(1):32\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"9362_CR34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaci.2013.02.019","volume":"132","author":"S Broesby-Olsen","year":"2013","unstructured":"Broesby-Olsen S, Kristensen T, Vestergaard H, Brixen K, M\u00f8ller MB, Bindslev-Jensen C, et al. KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis. J Allergy Clin Immunol. 2013;132(3):723\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9362_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","volume":"72","author":"R Weide","year":"1996","unstructured":"Weide R, Ehlenz K, Lorenz W, Walthers E, Klausmann M, Pfluger KH. Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Ann Hematol. 1996;72(1):41\u20133.","journal-title":"Ann Hematol"},{"issue":"3","key":"9362_CR36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajh.23931","volume":"90","author":"A Pardanani","year":"2015","unstructured":"Pardanani A. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Am J Hematol. 2015;90(3):250\u201362.","journal-title":"Am J Hematol"},{"issue":"6","key":"9362_CR37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/ard.2004.029116","volume":"64","author":"AY Lim","year":"2005","unstructured":"Lim AY, Ostor AJ, Love S, Crisp AJ. Systemic mastocytosis: A rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis. 2005;64(6):965\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"9362_CR38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10067-006-0369-0","volume":"26","author":"M Laroche","year":"2007","unstructured":"Laroche M, Bret J, Brouchet A, Mazi\u00e8res B. Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis. Clin Rheumatol. 2007;26(2):242\u20133.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"9362_CR39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/rheumatology\/36.3.393","volume":"36","author":"A Marshall","year":"1997","unstructured":"Marshall A, Kavanagh RT, Crisp AJ. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol. 1997;36(3):393\u20136.","journal-title":"Br J Rheumatol"},{"issue":"3","key":"9362_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/8756-3282(87)90014-7","volume":"8","author":"T Cundy","year":"1987","unstructured":"Cundy T, Beneton MN, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: Natural history and responses to treatment with inhibitors of bone resorption. Bone. 1987;8(3):149\u201355.","journal-title":"Bone"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-016-9362-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9362-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-016-9362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T09:04:06Z","timestamp":1600679046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-016-9362-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9362"],"URL":"https:\/\/doi.org\/10.1007\/s11154-016-9362-3","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,30]]}}}